PPT Slide

Proportion of patients with hepatitis B e antigen seroconversion at the end of

1-4 years of therapy with lamivudine (100 mg), analyzed with respect to whether

YMDD-variant hepatitis B virus was detectable

Lai et al., Clin. Infect. Dis. 36, 687-696 (2003)

Previous slide

Next slide

Back to first slide

View graphic version